E
Sell
3/14/2023Downgrade
Panacea Life Sciences Holdings, Inc. (PLSH) was downgraded to E+ from D- on 03/14/2023.
D
Sell
2/21/2023Upgraded
Panacea Life Sciences Holdings, Inc. (PLSH) was upgraded to D- from E+ on 2/21/2023 due to an increase in the volatility index and total return index.
E
Sell
11/17/2022Downgrade
Panacea Life Sciences Holdings, Inc. (PLSH) was downgraded to E+ from D- on 11/17/2022 due to a decline in the solvency index, volatility index and growth index. Debt to equity increased from 3.07 to 6.2, operating cash flow declined 67.32% from -$436 to -$729.5, and the quick ratio declined from 0.31 to 0.25.
D
Sell
5/5/2022Upgraded
Panacea Life Sciences Holdings, Inc. (PLSH) was upgraded to D- from E+ on 5/5/2022 due to an increase in the valuation index.
E
Sell
4/20/2022Downgrade
Panacea Life Sciences Holdings, Inc. (PLSH) was downgraded to E+ from D- on 4/20/2022 due to a major decline in the efficiency index.
D
Sell
4/1/2022Upgraded
Panacea Life Sciences Holdings, Inc. (PLSH) was upgraded to D- from E on 4/1/2022 due to an increase in the growth index, volatility index and solvency index.
E
Sell
1/3/2022Upgraded
Panacea Life Sciences Holdings, Inc. (PLSH) was upgraded to E from E- on 1/3/2022 due to an increase in the valuation index.
E
Sell
9/23/2021None
Panacea Life Sciences Holdings, Inc. (PLSH) was downgraded to E- from U on 09/23/2021.
